Christofori G - Search Results

1

Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy.

Pisarsky L, Bill R, Fagiani E, Dimeloe S, Goosen RW, Hagmann J, Hess C, Christofori G. Pisarsky L, et al. Among authors: christofori g. Cell Rep. 2016 May 10;15(6):1161-74. doi: 10.1016/j.celrep.2016.04.028. Epub 2016 Apr 28. Cell Rep. 2016. PMID: 27134168 Free PMC article.

2

An immature B cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse models.

Fagiani E, Bill R, Pisarsky L, Ivanek R, Rüegg C, Christofori G. Fagiani E, et al. Among authors: christofori g. Angiogenesis. 2015 Jul;18(3):327-45. doi: 10.1007/s10456-015-9470-9. Epub 2015 May 29. Angiogenesis. 2015. PMID: 26021306

3

Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis.

Fagiani E, Lorentz P, Kopfstein L, Christofori G. Fagiani E, et al. Among authors: christofori g. Cancer Res. 2011 Sep 1;71(17):5717-27. doi: 10.1158/0008-5472.CAN-10-4635. Epub 2011 Jul 21. Cancer Res. 2011. PMID: 21778249

4

Angiopoietins in angiogenesis.

Fagiani E, Christofori G. Fagiani E, et al. Among authors: christofori g. Cancer Lett. 2013 Jan 1;328(1):18-26. doi: 10.1016/j.canlet.2012.08.018. Epub 2012 Aug 23. Cancer Lett. 2013. PMID: 22922303 Review.

5

The relevance of EMT in breast cancer metastasis: Correlation or causality?

Bill R, Christofori G. Bill R, et al. Among authors: christofori g. FEBS Lett. 2015 Jun 22;589(14):1577-87. doi: 10.1016/j.febslet.2015.05.002. Epub 2015 May 12. FEBS Lett. 2015. PMID: 25979173 Free article. Review.

6

Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model.

Bill R, Fagiani E, Zumsteg A, Antoniadis H, Johansson D, Haefliger S, Albrecht I, Hilberg F, Christofori G. Bill R, et al. Among authors: christofori g. Clin Cancer Res. 2015 Nov 1;21(21):4856-67. doi: 10.1158/1078-0432.CCR-14-3036. Epub 2015 Jul 23. Clin Cancer Res. 2015. PMID: 26206868

7

The Rip1Tag2 Transgenic Mouse Model.

Bill R, Christofori G. Bill R, et al. Among authors: christofori g. Methods Mol Biol. 2016;1464:151-161. doi: 10.1007/978-1-4939-3999-2_14. Methods Mol Biol. 2016. PMID: 27858364

8

Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma.

Zumsteg A, Caviezel C, Pisarsky L, Strittmatter K, García-Echeverría C, Hofmann F, Christofori G. Zumsteg A, et al. Among authors: christofori g. Mol Cancer Res. 2012 Jun;10(6):800-9. doi: 10.1158/1541-7786.MCR-11-0522. Epub 2012 May 4. Mol Cancer Res. 2012. PMID: 22562956 Free article.

9

Junctional adhesion molecule B interferes with angiogenic VEGF/VEGFR2 signaling.

Meguenani M, Miljkovic-Licina M, Fagiani E, Ropraz P, Hammel P, Aurrand-Lions M, Adams RH, Christofori G, Imhof BA, Garrido-Urbani S. Meguenani M, et al. Among authors: christofori g. FASEB J. 2015 Aug;29(8):3411-25. doi: 10.1096/fj.15-270223. Epub 2015 Apr 24. FASEB J. 2015. PMID: 25911611

10

VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue.

Fagiani E, Lorentz P, Bill R, Pavotbawan K, Kopfstein L, Christofori G. Fagiani E, et al. Among authors: christofori g. Angiogenesis. 2016 Jul;19(3):339-58. doi: 10.1007/s10456-016-9508-7. Epub 2016 Apr 1. Angiogenesis. 2016. PMID: 27038485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters